Cargando…
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
INTRODUCTION: It is unclear how soon after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection it is safe to resume systemic anti-neoplastic treatment in patients with cancer. We assessed the risk of admissions or postponed treatment cycle in vaccinated patients with breast cancer...
Autores principales: | Halpern, Naama, Boursi, Ben, Shacham-Shmueli, Einat, Gal-Yam, Einav Nili, Margalit, Ofer, Golan, Talia, Beller, Tamar, Strauss, Gal, Yahav, Dafna, Leshem, Eyal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673789/ https://www.ncbi.nlm.nih.gov/pubmed/37864026 http://dx.doi.org/10.1007/s40487-023-00247-2 |
Ejemplares similares
-
Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients
por: Shmueli, Einat Shacham, et al.
Publicado: (2022) -
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma
por: Margalit, Ofer, et al.
Publicado: (2020) -
Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review
por: Halpern, Naama, et al.
Publicado: (2020) -
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
por: Margalit, Ofer, et al.
Publicado: (2022) -
Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study
por: Shacham-Shmueli, Einat, et al.
Publicado: (2022)